Informed choice of composite end points in cardiovascular trials G Gomez, M Gomez-Mateu, U Dafni Circulation: Cardiovascular Quality and Outcomes 7 (1), 170-178, 2014 | 44 | 2014 |
Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan E Negredo, A Bonjoch, M Gomez-Mateu, C Estany, J Puig, ... Public Library of Science 7 (10), e46031, 2012 | 25 | 2012 |
The asymptotic relative efficiency and the ratio of sample sizes when testing two different null hypotheses G Gómez Melis, M Gómez Mateu SORT: statistics and operations research transactions 38 (1), 73-88, 2014 | 19 | 2014 |
Young biostatisticians in Spain: career or race? A Lorenzo-Arribas, IM Silva, MG Mateu, NP Alvarez, HP Fabuel BEIO, Boletín de Estadística e Investigación Operativa 29 (3), 266-282, 2013 | 5 | 2013 |
Non-constant hazard ratios in randomized controlled trials with composite endpoints J Cortés Martínez, M Gómez Mateu, K Kim, G Gómez Melis ArXiv 1907 (10976), 1-17, 2019 | 1 | 2019 |
Clinical trial designs using CompARE. An on-line exploratory tool for investigators M Gómez Mateu, G Gómez Melis | 1 | 2017 |
Composite endpoints in clinical trials: computational tools, practical guidelines and methodological extensions M Gómez-Mateu Universitat Politècnica de Catalunya, 2016 | 1 | 2016 |
Comments on'Use of composite endpoints in clinical trials' by Abdul J. Sankoh, Haihong Li and Ralph B. D'Agostino, Sr. G Gómez, M Gómez-Mateu Statistics in Medicine 35 (2), 317-318, 2016 | 1 | 2016 |
Extensions and applications of CompARE: web platform to select the primary endpoint in a randomized clinical trial M Gómez Mateu, G Gómez Melis Current topics on risk analysis: ICRA 6 and RISK 2015 conference, 357-363, 2015 | | 2015 |
The asymptotic relative efficiency and the ratio of sample sizes when testing two different null hypotheses M Gómez-Mateu, G Gómez | | 2014 |
A Web-based Application as a Dynamical Tool for Clinical Trial Researchers M Gómez-Mateu, G Gómez The R User Conference, useR! 2013 July 10-12 2013 University of Castilla-La …, 2013 | | 2013 |
Recommendations to choose the primary endpoint in cardiovascular clinical trials G Gómez Melis, M Gómez Mateu, U Dafni | | 2013 |
Composite endpoints for stent cardiovascular clinical trials M Gómez Mateu Universitat Politècnica de Catalunya, 2011 | | 2011 |
Behaviour of the Hazard ratio in Composite endpoints M Gómez-Mateu, GG Melis | | |
CompARE: Web platform to choose the primary endpoint of a randomized clinical trial GG Melis, M Gómez-Mateu | | |
Opiniones sobre la profesión A Lorenzo-Arribas, UK Biomathematics and Statistics Scotland, ... | | |